LPA receptors are abundant in breast cancer and have been associated with activation and upregulation of PI3K/AKT, p38‐MAPK and ERK/MAPK signalling pathways, leading to cancer development and progression (Panupinthu et al., 2010). Here, AKT1 is linked to breast cancer.